| Product Code: ETC6739158 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cell And Gene Therapy Manufacturing Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 China Cell And Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 China Cell And Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 China Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 China Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F |
3.7 China Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 China Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 China Cell And Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in cell and gene therapy technologies in China |
4.2.2 Favorable government regulations and policies supporting the growth of cell and gene therapy manufacturing |
4.2.3 Growing collaborations between Chinese and international biopharmaceutical companies in the field of cell and gene therapy |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy manufacturing processes |
4.3.2 Regulatory challenges and uncertainties related to the approval and commercialization of cell and gene therapy products in China |
4.3.3 Limited skilled workforce specialized in cell and gene therapy manufacturing |
5 China Cell And Gene Therapy Manufacturing Market Trends |
6 China Cell And Gene Therapy Manufacturing Market, By Types |
6.1 China Cell And Gene Therapy Manufacturing Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F |
6.1.4 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F |
6.2 China Cell And Gene Therapy Manufacturing Market, By Scale |
6.2.1 Overview and Analysis |
6.2.2 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F |
6.2.3 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F |
6.3 China Cell And Gene Therapy Manufacturing Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F |
6.3.3 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F |
6.4 China Cell And Gene Therapy Manufacturing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F |
6.4.3 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F |
6.4.4 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F |
6.4.5 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F |
6.4.6 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F |
6.4.7 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F |
6.4.8 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 China Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 China Cell And Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 China Cell And Gene Therapy Manufacturing Market Export to Major Countries |
7.2 China Cell And Gene Therapy Manufacturing Market Imports from Major Countries |
8 China Cell And Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Number of clinical trials conducted in China for cell and gene therapy products |
8.2 Percentage increase in government funding allocated to support cell and gene therapy manufacturing |
8.3 Number of partnerships or collaborations formed between Chinese and international companies in the cell and gene therapy sector |
9 China Cell And Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 China Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 China Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F |
9.3 China Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 China Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 China Cell And Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 China Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 China Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here